Meet our team

Research Professor at CSIC (https://www.csic.es/en), Coordinator of the Nanomedicine Research Program of the CIBER-BBN (https://www.ciber-bbn.es/en), Coordinator of the Diagnostic Strategic Initiative of the PTI + Salud Global (https://pti-saludglobal-covid19.corp.csic.es/), Scientific Director of the Custom Antibody Service (CAbS), a facility of the ICTS NANBIOSIS (https://www.nanbiosis.es/), and Head of the Nanobiotechnology for Diagnostics (Nb4D) group (http://nb4d.iqac.csic.es/nb4d/). She is a world expert in the field of antibody-based technologies. Her current scientific activity addresses a future in which diagnosis will be based on personalized molecular fingerprints, which poses important technological challenges. Regarding the application of this technology, she is deeply involved in developing innovative approaches for the diagnosis of infectious diseases from an original perspective in which cellular communication becomes the key target. Most of her research is performed in the context of international collaborations with recognized research institutions, companies, and other stakeholders. She has been PI of a significant number of R&D projects (11 EC and more than 20 national projects in Spain, coordinating 8) and R&D contracts with international companies (21), most of them prolonged in time. She has co-authored more than 225 articles (h-index, 53 Google scholar) in international scientific journals of high-impact factor and has secured 15 patents, 4 of which have been licensed. She has signed 6 Exploitation Contracts from which 5 are active and generating revenues.